Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ estimates

Market news

17 October 2017

Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ estimates

Johnson & Johnson (JNJ) reported Q3 FY 2017 earnings of $1.90 per share (versus $1.68 in Q3 FY 2016), beating analysts' consensus estimate of $1.80.

The company's quarterly revenues amounted to $19.650 bln (+10.3% y/y), beating analysts' consensus estimate of $19.291 bln.

The company also raised FY2017 EPS guidance to $7.25-7.30 from $7.12-7.22 (versus analysts' consensus estimate of $7.18) and FY2017 revenues forecast to $76.1-76.5 bln from $75.8-76.1 bln (versus analysts' consensus estimate of $75.84 bln).

JNJ rose to $137.57 (+1.07%) in pre-market trading.

Company News: Morgan Stanley (MS) quarterly results beat analysts’ forecasts

Company News: Goldman Sachs (GS) quarterly results beat analysts’ expectations

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.